About REBETRON Combination Therapy REBETRON™ Combination Therapy containing REBETOL® (Ribavirin, USP) Capsules and INTRON® A (Interferon alfa-2b, recombinant) Injection, is used to treat patients with chronic hepatitis C. It is used in patients with compensated liver disease previously untreated with alpha interferon or who have relapsed following alpha interferon therapy. REBETOL® is the brand name of a drug called ribavirin. Ribavirin belongs to a group of drugs called nucleoside analogs, which are believed to prevent viruses from multiplying. Studies have found that the combination of REBETOL Capsules and INTRON A Injection helps to reduce the amount of virus found in a patient's blood (called "viral load"). INTRON® A is a manufactured form of interferon. Interferon is a protein made naturally by your body to boost your immunity to infection and regulate other cell functions. INTRON® A works by strengthening your body's immune system and preventing the virus from infecting healthy cells.                            REBETRON Combination Therapy could cause serious birth defects and harm (including death) to your unborn fetus. If you or your partner are pregnant, you should not receive REBETRON Combination Therapy. Pregnancy should not be planned while you or your partner are on therapy and for 6 months after therapy. (See Important Safety Information.) Choose a topic below: About REBETRON Combination Therapy Benefits of REBETRON Combination Therapy Who May Take REBETRON Combination Therapy? What to Expect During REBETRON Combination Therapy How REBETRON Combination Therapy Is Taken Side Effects and Safety Information 4 of 14 Terms and Conditions | Privacy Policy | Important Safety Information

The Importance of Treatment REBETRON Combination Therapy   Who May Take REBETRON Combination Therapy? What to Expect During REBETRON Combination Therapy Benefits of REBETRON Combination Therapy Side Effects and Safety Information How REBETRON Combination Therapy Is Taken INTRON® A Therapy